Boston Scientific (BSX) EBIT Growth (1y) (2010 - 2026)
Boston Scientific (BSX) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.20 Bn | 194.60 Bn | 7.27 Bn | -17.50% |
| 2 | Stryker | 129.69 Bn | 126.21 Bn | 4.50 Bn | 49.06% |
| 3 | Medtronic | 120.14 Bn | 110.92 Bn | 6.41 Bn | 30.43% |
| 4 | Boston Scientific | 74.16 Bn | 73.62 Bn | 3.85 Bn | 43.83% |
| 5 | Edwards Lifesciences | 52.68 Bn | 48.43 Bn | 1.35 Bn | 24.81% |
| 6 | Dexcom | 34.57 Bn | 32.62 Bn | 830.00 Mn | 49.72% |
| 7 | GE HealthCare Technologies | 34.09 Bn | 31.98 Bn | 2.18 Bn | 13.00% |
| 8 | Koninklijke Philips | 26.49 Bn | 23.17 Bn | 4.55 Bn | 57.74% |
| 9 | Steris | 23.19 Bn | 22.70 Bn | 684.20 Mn | 16.18% |
| 10 | Zimmer Biomet Holdings | 19.36 Bn | 18.95 Bn | 1.54 Bn | 8.70% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 43.83% |
| Mar 31, 2026 | 19.54% |
| Dec 31, 2025 | 22.22% |
| Sep 30, 2025 | 42.97% |
| Jun 30, 2025 | 57.50% |
| Mar 31, 2025 | 36.44% |
| Dec 31, 2024 | 15.58% |
| Sep 30, 2024 | 5.77% |
| Jun 30, 2024 | 1.17% |
| Mar 31, 2024 | 22.28% |
| Dec 31, 2023 | 45.27% |
| Sep 30, 2023 | 93.58% |
| Jun 30, 2023 | 21.51% |
| Mar 31, 2023 | 18.45% |
| Dec 31, 2022 | 123.33% |
| Sep 30, 2022 | -7.49% |
| Jun 30, 2022 | 61.45% |
| Mar 31, 2022 | 25.95% |
| Dec 31, 2021 | 260.00% |
| Sep 30, 2021 | 288.78% |